Literature DB >> 11207332

Personality disorder in multiple sclerosis correlates with cognitive impairment.

R H Benedict1, R L Priore, C Miller, F Munschauer, L Jacobs.   

Abstract

Previous studies of personality change in multiple sclerosis (MS) relied on brief, nonstandardized assessments or tests that are confounded with symptoms of acute psychiatric disorder. Objectives of the present study were to evaluate character change in MS by using comprehensive trait measures of personality and to determine if there is an association between personality change and cognitive dysfunction. Thirty-four MS patients and 14 healthy volunteers were studied. All underwent comprehensive neurologic and neuropsychologic evaluation. Personality assessments included both self and informant reports on the Hogan Empathy Scale and the NEO Personality Inventory. Abnormalities were found among MS patients indicating elevated neuroticism and reduction in empathy, agreeableness, and conscientiousness. Large patient/informant discrepancies were observed in the MS but not the control group. Three neuropsychological tests emphasizing executive control predicted the presence of these abnormalities; this association suggests a neurogenic, frontal lobe syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11207332     DOI: 10.1176/jnp.13.1.70

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  29 in total

1.  Neuropsychological correlates of normal variation in emotional response to visual stimuli.

Authors:  Robert G Robinson; Sergio Paradiso; Romina Mizrahi; Jess G Fiedorowicz; Dimitrios E Kouzoukas; David J Moser
Journal:  J Nerv Ment Dis       Date:  2007-02       Impact factor: 2.254

2.  Protective personality traits: High openness and low neuroticism linked to better memory in multiple sclerosis.

Authors:  Victoria M Leavitt; Korhan Buyukturkoglu; Matilde Inglese; James F Sumowski
Journal:  Mult Scler       Date:  2017-01-09       Impact factor: 6.312

3.  The NEO-FFI in Multiple Sclerosis: internal consistency, factorial validity, and correspondence between self and informant reports.

Authors:  Eben S Schwartz; Benjamin P Chapman; Paul R Duberstein; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Assessment       Date:  2010-05-19

4.  Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.

Authors:  L B Strober
Journal:  Psychol Health Med       Date:  2016-03-18       Impact factor: 2.423

5.  White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.

Authors:  Tom A Fuchs; Michael G Dwyer; Amy Kuceyeski; Sanjeevani Choudhery; Keith Carolus; Xian Li; Matthew Mallory; Bianca Weinstock-Guttman; Dejan Jakimovski; Deepa Ramasamy; Robert Zivadinov; Ralph H B Benedict
Journal:  Hum Brain Mapp       Date:  2018-05-08       Impact factor: 5.038

6.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

7.  Functional Changes after Recombinant Human Growth Hormone Replacement in Patients with Chronic Traumatic Brain Injury and Abnormal Growth Hormone Secretion.

Authors:  Kurt A Mossberg; William J Durham; Dennis J Zgaljardic; Charles R Gilkison; Christopher P Danesi; Melinda Sheffield-Moore; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2016-10-13       Impact factor: 5.269

8.  Effects of single dose mixed amphetamine salts--extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.

Authors:  Sarah A Morrow; Heather Rosehart
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

9.  Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.

Authors:  Kira Ashton; Tom A Fuchs; Devon Oship; Robert Zivadinov; Dejan Jakimovski; Niels Bergsland; Deepa P Ramasamy; Caila Vaughn; Bianca Weinstock-Guttman; Ralph H B Benedict; Michael G Dwyer
Journal:  J Neurol       Date:  2020-08-04       Impact factor: 4.849

10.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.